RxDoctor Payments Data

Robert Lipetz

Family Medicine · Spring Valley, CANPI 1467524785

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $276 of the $309 with a category attached, or 89.5%. Every reported general payment came from a single manufacturer, Novo Nordisk.

$309in general payments, 2019–2025

Across 10 payments — averaging $30.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$309
$818,751in research payments, 2019–2025

Across 156 payments — averaging $5248.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$501K
  • AbbVie$109K
  • GSK$56K
  • Pfizer$38K
  • Janssen Research & Development, LLC$31K
  • Novartis$28K
  • plus $56K from 4 others

What the payments were for

  • Food & beverage$27690%
  • Education$3210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk10$309

How this compares

$309 in reported general payments places this provider in the 55th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Other family medicine in Spring Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →